January 2, 2018 - Healing Blends Global has proudly announced that it will conduct a Sickle Cell double-blind study in Kisumu, Kenya. The high-end medical research by the institute will be done in collaboration with Uzima University Medical School, and the research study will have great significance for the treatment of sickle cell patients worldwide. The targeted age group for this upcoming research study is between 6-12 years old children and the recruitment for the participants of this study was started on December 6th, 2017, while the study will begin on January 4th, 2018.
“The study will be carried out by Professor Richard Muga, Arthur Ajwang and medical team at the Uzima University Medical School and our company, Healing Blends Global,” said the spokesperson of Healing Blends Global, while talking about the research. “We are placing this research as a very significant project for our brand because as the manufacturers of Even Flo, this research will be the ultimate test of our product and its formula,” he added. Even Flo is an all-natural supplement that was created by Dr. Charlie Ware in the USA more than a decade ago, and this research will test its abilities like never before
In addition, the study will evaluate the effectiveness of Even Flo, which is an all-natural supplement used in reducing the frequency of crises in sickle cell patients. According to the spokesperson of Healing Blends Global, the study will take place at Jaramogi Oginga Odinga Teaching and Referral Hospital Kisumu Obama Children’s Clinic.
Moreover, Kenyans have been using Even Flo for over three years, and parents have witnessed great success with the product thus expressing positive feedback of how efficiently Even Flo works.
For more information, please visit: www.kisumunews.com/sickle-cell-double-blind-study-in-kisumu
Media Contact
Company Name: Healing Blends Global
Contact Person: Caroline Ware
Email:Send Email
Phone: 954-458-5999
Country: United States
Website: http://www.healingblendsglobal.com/
